Thursday, May 24, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Area: Clinical Research
Wedded bliss?
NGP talks to GSK’s Paul Matthews about the unique challenges posed by the marriage of imaging and drug development.
No Comments
Streamlining data
Amy Furlong of ERT explains why a centralized data system is more reliable.
No Comments
Benefiting from appropriate imaging modality
How the integration of appropriate imaging modality increases the efficiency of clinical trials. By Michael Morales and Bruce Hillman, ACR Image Metrix
No Comments
The beauty of personalized medicine
Personalized medicine is rapidly changing the healthcare industry providing new opportunities for biotechnology companies.
No Comments
The suite life: The future of clinical development
Over the last several years, the pharmaceutical industry has been fundamentally transforming its core business model of producing "blockbuster drugs" aimed at large patient populations with high sales potential.
No Comments
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.